https://www.selleckchem.com/products/harmine.html
w Zealand Clinical Trials Registry (ANZCTR) and allocated the ACTRN ACTRN12618000286246. Registered on 23 February 2018. Economic findings suggest that implementation of MAS within the Australian context is cost effective.Trial registration Registered with Australian New Zealand Clinical Trials Registry (ANZCTR) and allocated the ACTRN ACTRN12618000286246. Registered on 23 February 2018. Gastric cancer is a serious malignant tumor associated with aberrant circular RNAs (circRNAs) expression. In this study, we aim to investigate the role
Like
Comment
Share
